Retinitis Pigmentosa

Bionic eyes offering better sight to blind

A brighter ray of hope is on the horizon for the blind, as scientists improve electronic hardware that creates sight - making it possible, they predict, to read printed text, recognize faces and lead normal, independent lives.

Feb 15, 2015
popularity 5 / 5 (8) | comments 0

Inducing visual function

Scientists from the groups of Botond Roska and Witold Filipowicz at the Friedrich Miescher Institute for Biomedical Research have resolved the mechanism controlling the maintenance of the light sensitive ...

Jul 02, 2014
popularity 5 / 5 (3) | comments 0

Retinitis pigmentosa (RP) is a group of genetic eye conditions that leads to incurable blindness. In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years or even decades. Many people with RP do not become legally blind until their 40s or 50s and retain some sight all their lives. Others go completely blind from RP, in some cases as early as childhood. Progression of RP is different in each case.

RP is a type of progressive retinal dystrophy, a group of inherited disorders in which abnormalities of the photoreceptors (rods and cones) or the retinal pigment epithelium (RPE) of the retina lead to progressive visual loss. Affected individuals first experience defective dark adaptation or nyctalopia (night blindness), followed by reduction of the peripheral visual field (known as tunnel vision) and, sometimes, loss of central vision late in the course of the disease.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Twitter helps smokers kick the habit, study finds

When subjects in a smoking cessation program tweet each other regularly, they're more successful at kicking the habit, according to a study by UC Irvine and Stanford University researchers. Specifically, ...

GDNF not needed by the midbrain dopamine system

A key factor in the motor symptoms associated with Parkinson's disease is the gradual destruction of dopamine neurons. The glial cell-derived neurotrophic factor, or GDNF, has been proven to protect dopamine neurons in test ...

Curtailing worry reduces key schizophrenia symptom

Delusions of persecution in psychiatric patients can be reduced with just six sessions of cognitive behavioural therapy (CBT), a new clinical trial has found. Using CBT in this way could potentially help ...

Hidden hazards found in green products

A University of Melbourne researcher has found that common consumer products, including those marketed as 'green', 'all-natural', 'non-toxic', and 'organic', emit a range of compounds that could harm human ...